ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, but it crossed this line recently, which means that it could show a small or a large recovery soon enough depending on its trend.

My analysis of Editas Medicine is bearish for shortterm, and stock might move down till 2.8 or till 2.4. Use a stoploss of 3.11 and if the stock hits stoploss, then it can shoot up till 3.44

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

US Stock Market: Healthy loan growth and stable credit trends boost outlook for US bank stocks Major Wall Street banks say the U.S. consumer remains resilient, with strong spending, rising loan balances and stable credit quality backed by a healthy labour market and wage growth. While inflation, higher borrowing costs and geopolitical tensions remai - NEWS as on 2026-07-16 indiatimes.com

TVS Venu Group firm Home Credit India to acquire Varthana Finance for Rs 967 crore Home Credit India Finance will acquire Varthana Finance for Rs 967 crore. This all-cash transaction is subject to regulatory approvals from the Reserve Bank of India. The acquisition will strengthen TVS Venu Group's financial services sector presence. Vart - NEWS as on 2026-07-15 indiatimes.com

US Stock Market: Private credit lending slumps in Q2 despite rebound in fundraising US private credit funds raised significant capital in the second quarter. Direct lending activity, however, saw a sharp decline during the same period. This divergence highlights investor capital outpacing available new lending opportunities. Private equit - NEWS as on 2026-07-10 indiatimes.com

Bank credit growth to ease as corporates tap bond markets, overseas funding: CareEdge Bank credit growth is expected to moderate gradually in the upcoming fiscal year. Large corporations will increasingly use domestic bond markets and overseas borrowings for funding. The Reserve Bank of India's policy measures make external funding more att - NEWS as on 2026-07-09 indiatimes.com

Credit cards are losing ground to small personal loans, TransUnion CIBIL data shows Credit cards are losing share in India's unsecured lending market as consumers increasingly opt for small-ticket personal loans and other consumption-linked credit, according to a TransUnion CIBIL report. - NEWS as on 2026-07-08 indiatimes.com

Manufacturing MSME credit growth slows to three-year low: Report Manufacturing MSMEs are experiencing the slowest credit growth in three years, raising concerns about lenders' strategies. Only 41% of registered small businesses have accessed formal credit, and the share of new borrowers is declining. While trades and se - NEWS as on 2026-07-03 indiatimes.com

India's private credit market doubles to billion AUM in five years: Report India's private credit market is booming, nearly doubling to billion in assets under management over five years, fueled by strong business demand. The Insolvency and Bankruptcy Code has boosted lender confidence, enabling financing for stressed firms. - NEWS as on 2026-07-02 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 3.05
  • 12Day Average: 3.32
  • 20Day Average: 3.14
  • 50Day Average: 2.96
  • 100Day Average: 2.81
  • 150Day Average: 2.57
  • 200Day Average: 2.69

EDIT Indicators & signals

Indicator MACD (12,26,9)

3.14, 3.07, 0.12
Indicator MACD is in positive zone

Indicator ADX (14)

17.65, 25, 35.71
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 51
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Fri Jul 2026 2.98 2.77 to 3.03 3.47% 0.73 times
16 Thu Jul 2026 2.88 2.82 to 3.01 -5.26% 0.58 times
15 Wed Jul 2026 3.04 2.99 to 3.17 -4.1% 0.67 times
14 Tue Jul 2026 3.17 3.05 to 3.21 0.32% 0.6 times
13 Mon Jul 2026 3.16 3.04 to 3.19 -3.07% 0.87 times
10 Fri Jul 2026 3.26 2.96 to 3.30 -0.91% 1.3 times
09 Thu Jul 2026 3.29 3.26 to 3.72 -10.11% 1.27 times
08 Wed Jul 2026 3.66 3.54 to 3.82 -2.4% 0.86 times
07 Tue Jul 2026 3.75 3.52 to 3.82 2.74% 1.03 times
06 Mon Jul 2026 3.65 3.55 to 3.79 0% 1.24 times
02 Thu Jul 2026 3.65 3.17 to 3.68 10.94% 1.58 times
01 Wed Jul 2026 3.29 3.13 to 3.49 1.23% 1.09 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top